PharmaCyte Biotech Inc (PMCB)

[pennyvestor]

In connection with the 2021 Annual Meeting of Stockholders of PharmaCyte Biotech, Inc. (“PharmaCyte”), beginning on or about May 5, 2021, a Notice Regarding Availability of Proxy Materials (“Notice”) was mailed to all stockholders of record as of April 19, 2021. The Annual Meeting of Stockholders will be held virtually at https://www.virtualshareholdermeeting.com/PMCB2021 on Wednesday, June 16, 2021 at 11:00 a.m., Pacific Daylight Time, to consider and vote on the following matters:



1. To elect seven directors as nominated by the Board of Directors of PharmaCyte (“Board”), each to serve a one-year term;


2. To approve a Certificate of Amendment to PharmaCyte’s Articles of Incorporation to increase the number of our authorized shares of common stock;


3. To approve PharmaCyte’s 2021 Equity Incentive Plan; and


4. To ratify PharmaCyte’s appointment of Armanino LLP as PharmaCyte’s independent registered public accounting firm for the fiscal year ending April 30, 2022.


All stockholders will have the ability to access the proxy materials and our Annual Report on Form 10-K for the fiscal year ended April 30, 2020, as amended, on a website referred to in the Notice or to request to receive a printed set of the proxy materials and the Annual Report. The Notice of Annual Meeting and Proxy Statement is filed as Exhibit 99.1 and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



99.1 Notice of Annual Meeting of Stockholders and Proxy Statement.

https://ir.pharmacyte.com/all-sec-filings/content/0001683168-21-001793/pharmacyte_8k.htm